Evidence map›Paper›PMID 29198440›Full record

ReviewTrends in cancer2017

Fanconi Anemia Signaling and Cancer.

Manoj Nepal, Raymond Che, Jun Zhang, Chi Ma, Peiwen Fei

Abstract readReview
In one paragraph

Review in Trends in cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Review
  3. FANCD2 promotes wound healing through DNMT1.Histochemistry and cell biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Missense Variants in Nutrition-Related Genes: A Computational Study.International journal of molecular sciences · 2025
    Article
  9. UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manoj NepalUniversity of Hawaii Cancer Center, Honolulu, HI, USA; Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI, USA; Equal contribution.
Raymond CheUniversity of Hawaii Cancer Center, Honolulu, HI, USA; Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI, USA; Equal contribution.
Jun ZhangDepartment of Laboratory Medicine and Pathology, Mayo Clinic Foundation, USA.
Chi MaUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Peiwen FeiUniversity of Hawaii Cancer Center, Honolulu, HI, USA; Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI, USA. Electronic address: pfei@cc.hawaii.edu.

Funding

Molecular Insights into the Fanconi Anemia Tumor Suppressor Signaling PathwayR01CA188251 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI FEI, PEIWEN · 2014 to 2018
$1.6M
Roles of the Fanconi Anemia Pathway in Bladder TumorigenesisR01CA136532 · NCI · UNIVERSITY OF MINNESOTA · PI FEI, PEIWEN · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA136532NCI NIH HHS R01 CA188251
6 · The paper itself

Abstract

The extremely high cancer incidence associated with patients suffering from a rare human genetic disease, Fanconi anemia (FA), demonstrates the importance of FA genes. Over the course of human tumor development, FA genes perform critical tumor-suppression roles. In doing so, FA provides researchers with a unique genetic model system to study cancer etiology. Here, we review how aberrant function of the 22 FA genes and their signaling network contributes to malignancy. From this perspective, we will also discuss how the knowledge discovered from FA research serves basic and translational cancer research.

Indexed as

DNA DamageFanconi AnemiaFanconi Anemia Complementation Group ProteinsHumansNeoplasmsProtein Processing, Post-TranslationalSignal TransductionFanconi Anemia Complementation Group ProteinsATM/ATRcancerFanconi anemia signalinggenome instabilitytumor development and resistance

Identifiers

PMID29198440
PMCPMC5819365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.